People who have both severe mental illness (SMI) and obstructive airways disease (OAD) experience extraordinary disability and isolation, which leads to a lack of access to care and increased use of urgent care.
People with severe mental illness (SMI) also have a higher prevalence of physical comorbidities compared with the general population. Patients with SMI also face barriers to care, necessitating collaborative, personalized care that improves self-management and enhancing access to care, according to a study published in BMJ Open.
Researchers evaluated patient and stakeholder perspectives of primary respiratory care for people with SMI and comorbid obstructive airways disease (OAD) and found that these patients are experiencing extraordinary disability and isolation as a result of having both SMI and OAD.
The authors noted the link between OAD and SMI “is partially explained by higher rates of smoking tobacco and/or cannabis, but socioeconomic deprivation and other environmental factors may also be relevant.”
They used a qualitative interpretive phenomenological study to understand the experiences of people with SMI and OAD receiving respiratory health care in the primary care setting. They interviewed 16 patients (9 women and 7 men) between the ages of 45 and 75 years old. Most (n = 10) had comorbid asthma and the rest (n = 6) had chronic obstructive pulmonary disease (COPD).
While 1 patient was receiving care for COPD at a hospital clinic, 10 lived alone and “almost all lived in areas of significant socioeconomic deprivation. Twelve patients were current smokers or ex-smokers. In addition, 12 patients were either unemployed or had retired.
The data collected was split into 3 themes:
The interviews also highlighted that the “complex interplay of social, mental and physical challenges experienced by our participants contributed to normalisation of poor physical health.” As a result, the participants had increased use of urgent care.
The researchers presented the results at a public stakeholder event attended by people who lived with SMI, charity workers, clinicians, and more. A total of 21 people participated in 3 discussion groups and they “expressed similar concerns about gaps in care,” the authors wrote.
“Potential solutions focused on adequate resources, supported navigation of care pathways, relational continuity, individual and community asset building and the evolving integrated social prescriber role,” they added.
The stakeholders were in favor of a redesign that mandated inclusive access to health care as well as the use of a tailored “social prescribing” intervention, which can enhance the self-management skills and the social networks of patients with SMI and OAD.
The researchers suggested future research on developing integrated personalized health and social care interventions for this patient population.
“The provision of personalised, collaborative health and social care for this group, which prioritises relational continuity by practitioners, builds individual social capital, tailors support for self-management and addresses barriers in access toprimary care appointments is warranted,” the authors concluded.
Reference
Mitchell C, Zuraw N, Delaney B, et al. Primary care for people with severe mental illness and comorbid obstructive airways disease: a qualitative study of patient perspectives with integrated stakeholder feedback. BMJ Open. 2022;12(3):e057143. doi:10.1136/bmjopen-2021-057143
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
2 Commerce Drive
Cranbury, NJ 08512